Royal Prima PT (PRIM) - Total Liabilities

Latest as of September 2025: Rp111.14 Billion IDR ≈ $6.51 Million USD

Based on the latest financial reports, Royal Prima PT (PRIM) has total liabilities worth Rp111.14 Billion IDR (≈ $6.51 Million USD) as of September 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check Royal Prima PT (PRIM) asset resilience to evaluate the company's liquid asset resilience ratio.

Royal Prima PT - Total Liabilities Trend (2014–2024)

This chart illustrates how Royal Prima PT's total liabilities have evolved over time, based on quarterly financial data. For the complete balance sheet picture, see Royal Prima PT (PRIM) total assets.

Royal Prima PT Competitors by Total Liabilities

The table below lists competitors of Royal Prima PT ranked by their total liabilities.

Company Country Total Liabilities
Lithium Energy Ltd
AU:LEL
Australia AU$2.64 Million
Inventec Besta Co Ltd
TW:8201
Taiwan NT$176.56 Million
Smartlink Holdings Limited
NSE:SMARTLINK
India Rs639.48 Million
Kyobo 3 SPAC
KQ:208710
Korea ₩41.78 Billion
Zee Learn Limited
NSE:ZEELEARN
India Rs13.58 Billion
Rifa Ind
KO:000760
Korea ₩64.66 Billion
HAMILTON GLB.OPP.LS-0001
F:5DS
Germany €5.46 Million
Shiva Texyarn Limited
NSE:SHIVATEX
India Rs1.65 Billion

Liability Composition Analysis (2014–2024)

This chart breaks down Royal Prima PT's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. See how leveraged is Royal Prima PT's balance sheet to measure how much of total assets are equity-financed.

Liquidity & Leverage Metrics

Key Metrics Explained

Metric Value Description
Current Ratio 1.77 Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities)
Quick Ratio N/A More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities)
Cash Ratio 0.05 Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities)
Debt to Equity 0.12 Measures financial leverage (Total Liabilities ÷ Shareholder Equity)
Debt to Assets 0.10 Portion of assets financed with debt (Total Liabilities ÷ Total Assets)

Liability Trends Comparison

This chart compares key liability metrics across different time periods, showing how Royal Prima PT's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.

Annual Total Liabilities for Royal Prima PT (2014–2024)

The table below shows the annual total liabilities of Royal Prima PT from 2014 to 2024.

Year Total Liabilities Change
2024-12-31 Rp122.17 Billion
≈ $7.16 Million
+145.89%
2023-12-31 Rp49.69 Billion
≈ $2.91 Million
-4.20%
2022-12-31 Rp51.86 Billion
≈ $3.04 Million
-68.97%
2021-12-31 Rp167.11 Billion
≈ $9.79 Million
+174.17%
2020-12-31 Rp60.95 Billion
≈ $3.57 Million
+0.95%
2019-12-31 Rp60.38 Billion
≈ $3.54 Million
-4.81%
2018-12-31 Rp63.43 Billion
≈ $3.72 Million
+7.11%
2017-12-31 Rp59.22 Billion
≈ $3.47 Million
+126.60%
2016-12-31 Rp26.13 Billion
≈ $1.53 Million
-0.95%
2015-12-31 Rp26.38 Billion
≈ $1.55 Million
+89.58%
2014-12-31 Rp13.92 Billion
≈ $815.50K
--

About Royal Prima PT

JK:PRIM Indonesia Medical Care Facilities
Market Cap
$24.15 Million
Rp412.16 Billion IDR
Market Cap Rank
#24591 Global
#520 in Indonesia
Share Price
Rp122.00
Change (1 day)
-0.81%
52-Week Range
Rp68.00 - Rp123.00
All Time High
Rp1640.00
About

PT Royal Prima Tbk engages in providing hospital services in Indonesia. The company operates its hospitals under the Royal Prima Medan, Royal Prima Jambi, and RSU Royal Prima Marelan names. It provides health services, such as emergency, outpatient, inpatient, laboratorium, radiology, medical rehab, pharmacy, and MCU; and general surgery, internist, VCT, ICU, cardiology, urology, haemodialysis, m… Read more